Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV1.7 sodium channels
出版年份 2014 全文链接
标题
Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV1.7 sodium channels
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume 171, Issue 19, Pages 4455-4463
出版商
Wiley
发表日期
2014-05-28
DOI
10.1111/bph.12788
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- A Novel SCN9A Mutation Responsible for Primary Erythromelalgia and Is Resistant to the Treatment of Sodium Channel Blockers
- (2013) Min-Tzu Wu et al. PLoS One
- Painful Na-channelopathies: an expanding universe
- (2013) Stephen G. Waxman TRENDS IN MOLECULAR MEDICINE
- Mexiletine for Symptoms and Signs of Myotonia in Nondystrophic Myotonia
- (2012) Jeffrey M. Statland JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Modulation of neuronal sodium channels by the sea anemone peptide BDS-I
- (2012) Pin Liu et al. JOURNAL OF NEUROPHYSIOLOGY
- Biophysical characterization of M1476I, a sodium channel founder mutation associated with cold-induced myotonia in French Canadians
- (2012) Juan Zhao et al. JOURNAL OF PHYSIOLOGY-LONDON
- Imaging the neural correlates of neuropathic pain and pleasurable relief associated with inherited erythromelalgia in a single subject with quantitative arterial spin labelling
- (2012) Andrew R. Segerdahl et al. PAIN
- Structural modelling and mutant cycle analysis predict pharmacoresponsiveness of a Nav1.7 mutant channel
- (2012) Yang Yang et al. Nature Communications
- Deletion mutation of sodium channel NaV1.7 in inherited erythromelalgia: enhanced slow inactivation modulates dorsal root ganglion neuron hyperexcitability
- (2011) X. Cheng et al. BRAIN
- Lidocaine reduces the transition to slow inactivation in Nav1.7 voltage-gated sodium channels
- (2011) Patrick L Sheets et al. BRITISH JOURNAL OF PHARMACOLOGY
- Intra- and Interfamily Phenotypic Diversity in Pain Syndromes Associated with a Gain-of-Function Variant of NaV1.7
- (2011) Mark Estación et al. Molecular Pain
- Intravenous Lidocaine and Mexiletine in the Management of Trigeminal Autonomic Cephalalgias
- (2010) Michael J. Marmura Current Pain and Headache Reports
- A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia
- (2009) Tanya Z. Fischer et al. ANNALS OF NEUROLOGY
- The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment
- (2009) E. Matthews et al. BRAIN
- Mexiletine-responsive erythromelalgia due to a new Nav1.7 mutation showing use-dependent current fall-off
- (2009) Jin-Sung Choi et al. EXPERIMENTAL NEUROLOGY
- Compound Heterozygosity in Sodium Channel Nav1.7 in a Family with Hereditary Erythermalgia
- (2008) Mark E Samuels et al. Molecular Pain
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started